trending Market Intelligence /marketintelligence/en/news-insights/trending/KpwnqdUVLMtJk18qcrrd6w2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Illumina profit beats consensus by 36.9% in Q3

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Illumina profit beats consensus by 36.9% in Q3

Illumina Inc. said its third-quarter non-GAAP EPS was $1.93, compared with the S&P Global Market Intelligence consensus normalized EPS estimate of $1.41 per share.

EPS climbed 27% year over year from $1.52.

Non-GAAP net income attributable to stockholders totaled $286 million, an increase of 26% from $227 million in the prior-year period.

Total revenue grew 6.3% year over year to $907 million from $853 million.

GAAP net income attributable to stockholders rose 17.6% on an annual basis to $234 million, or $1.58 per share, from $199 million, or $1.33 per share.

Illumina forecasts non-GAAP EPS in the range of $6.40 to $6.45 for the full year 2019, compared with the previous outlook in the range of $6 to $6.10. The company also expects GAAP EPS in the range of $6.55 to $6.60 for the full year, compared with prior estimates in the range of $6.41 to $6.51.